Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Samples from Chobani yogurt contain most virulent form of fungus

Samples isolated from Chobani yogurt that was voluntarily recalled in September 2013 have been found to contain the most virulent form of a fungus called Mucor circinelloides, which is associated with infections in immune-compromised people.

8 Jul 2014

Grunenthal Group submits Marketing Authorization Application to EMA for ZALVISO

AcelRx Pharmaceuticals, Inc. and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization Application (MAA) to the European Medicines Authority for ZALVISO for the management of moderate to severe acute pain in adult patients in a medically supervised environment.

7 Jul 2014

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.

7 Jul 2014

Viewpoints: Expanding Hobby Lobby decision; the faux war on women; dispute over pelvic exams

The Supreme Court wasted no time in delivering a message to anyone who thought its Hobby Lobby ruling was limited to religious objections to coverage of purported abortion methods: You're wrong.

4 Jul 2014

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.

4 Jul 2014

Scientists produce drug compound with potential to block HIV transmission in women

Scientists at the University of Nebraska-Lincoln College of Engineering's Biological Process Development Facility have successfully produced a drug compound with potential to block HIV transmission in women.

4 Jul 2014

Eurofins Genomics, AmpTec sign co-marketing agreement for IVT-RNAs

Eurofins Genomics, international market leader in genomic services, and AmpTec, internationally recognized provider of RNA technology products, have agreed on non-exclusively co-marketing AmpTec's IVT-RNAs globally.

2 Jul 2014

Study: Lead in children's' blood linked to increased emotional and behavioral problems

Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.

1 Jul 2014

Quantum Materials secures anti-counterfeiting quantum dot detection technology

Quantum Materials Corporation (OTCQB:QTMM) announces securing 3D printing and additive manufacturing anti-counterfeiting quantum dot detection technology developed at the Institute for Critical Technology and Applied Science and the Design, Research, and Education for Additive Manufacturing Systems (DREAMS) Laboratory at Virginia Tech.

30 Jun 2014

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilaç.

30 Jun 2014

Valent Biosciences opens new biorational manufacturing facility in Iowa

Valent BioSciences Corporation (VBC) today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries, state and local VIPs, and media personnel.

28 Jun 2014

New technique improves quality of flexible, conductive, transparent glass

A new technique developed by a Binghamton University physicist and his colleagues will improve the quality of flexible, conductive, transparent glass. (The sort that's needed for Minority Report-style giant computer displays.)

27 Jun 2014

Animal study: Common BPA substitute alters brain development, causes hyperactive behavior

A chemical found in many "BPA free" consumer products, known as bisphenol S (BPS), is just as potent as bisphenol A (BPA) in altering brain development and causing hyperactive behavior, an animal study finds.

24 Jun 2014

Arcam receives order from DiSanto Technology for two Arcam Q10 systems

Arcam, listed on NASDAQ OMX, has received an order for two Arcam Q10 systems from the strategic partner DiSanto Technology Inc. in the US. The systems will be used for manufacturing of orthopedic implants.

24 Jun 2014

Generic drug delays cost U.S. payers millions

Problems surrounding an Indian company's launch of generic versions of three blockbuster drugs have preserved millions in revenue for the brand-name makers, reports The Wall Street Journal.

19 Jun 2014

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

First Edition: June 18, 2014

Today's headlines include a report that the cost of health law subsidies may push the measure's overall price tag beyond projections.

18 Jun 2014

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.

18 Jun 2014

Western Oncolytics closes $275,000 in seed funding

Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill cancer cells.

18 Jun 2014

Eden licenses Sandia’s technology to develop radioactive isotope for medical diagnostic tests

An Albuquerque startup company has licensed a Sandia National Laboratories technology that offers a way to make molybdenum-99, a key radioactive isotope needed for diagnostic imaging in nuclear medicine, in the United States.

18 Jun 2014

Manufacturing News and Research

Further Reading

Samples from Chobani yogurt contain most virulent form of fungus

Grunenthal Group submits Marketing Authorization Application to EMA for ZALVISO

Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 million

Viewpoints: Expanding Hobby Lobby decision; the faux war on women; dispute over pelvic exams

TxCell announces launch of POSITIVE project to automate manufacturing process for Ovasave

Scientists produce drug compound with potential to block HIV transmission in women

Eurofins Genomics, AmpTec sign co-marketing agreement for IVT-RNAs

Study: Lead in children's' blood linked to increased emotional and behavioral problems

Quantum Materials secures anti-counterfeiting quantum dot detection technology

Helsinn Group grants GEN Ilaç anamorelin rights for Turkey

Valent Biosciences opens new biorational manufacturing facility in Iowa

New technique improves quality of flexible, conductive, transparent glass

Animal study: Common BPA substitute alters brain development, causes hyperactive behavior

Arcam receives order from DiSanto Technology for two Arcam Q10 systems

Generic drug delays cost U.S. payers millions

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

First Edition: June 18, 2014

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

Western Oncolytics closes $275,000 in seed funding

Eden licenses Sandia’s technology to develop radioactive isotope for medical diagnostic tests

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News